HA · 醫院管理局法定機構Contract No. DSQ25-217

Supply of Rilpivirine IM PR Injection 300mg/ml 3ml

已批出 / AwardedContract Award

醫院管理局招標「Supply of Rilpivirine IM PR Injection 300mg/ml 3ml」。合約／招標編號 DSQ25-217。狀態為已批出，承辦商 GlaxoSmithKline Limited，金額 HKD9.88Mn。

Hospital Authority tender “Supply of Rilpivirine IM PR Injection 300mg/ml 3ml”; Contract No. DSQ25-217; status Awarded, contractor GlaxoSmithKline Limited, amount HKD9.88Mn.

合約／招標編號 Contract No.: DSQ25-217
截止日期 / 批出 Close / Award: 8-May-2026
承辦商 Contractor: GlaxoSmithKline Limited
金額 Amount: HKD9.88Mn
發出機構 Issuer: 醫院管理局 Hospital AuthoritySource: ha-notices
更新 Updated: 16/7/2026 16:08:38

聯絡 Contact

—

官方來源 Official source 返回看板 Back to board